Business Strategy

#SDG3: Big pharma's blueprint to bring health access to all

Mark Hillsdon, (Jun 14, 2017)

With cancer and diabetes now more prevalent in poor countries than in the West, 23 companies, including Pfizer, Novartis, GlaxoSmithKline and Japan's Takeda, are developing partnerships in some of the hardest-hit regions to extend access to life-saving medicines

Deconstructing CSR: Competitiveness

Oliver Balch, (Jun 14, 2017)

Oliver Balch tackles key topics in academic thinking and research on sustainability

The importance of sustainability is being recognised

Nelson Switzer., (Jun 9, 2017)

Thoughts on the trends and insights from the Responsible Business Trends Report 2017

Responsible Business Trends Report 2017 - Foreword

Jim G. Vella, (Jun 9, 2017)

Feedback on the Responsible Business Trends 2017 report

Paul Polman on the need for business leadership

Conference Recording, (Jun 9, 2017)

CSR Cheat Sheet: SDGs failing to resonate

Oliver Balch, (Jun 6, 2017)

New blueprint for UN Principles for Responsible Investment, activist shareholders gain ground, internal carbon pricing rises

How ING links profits to purpose

Rebecca Ley, (Jun 6, 2017)

Leon Wijnands, global head of sustainability, talks about how the Dutch bank wants to do away with a sustainability department by making it core to the business

Selling the poor on better sanitation

EC Newsdesk, (May 31, 2017)

Efforts to eradicate open defecation and unhygienic toilets in countries like India can succeed with a well-designed private-sector led approach, Scott Roy and W Roy Whitten argue

Pages